Sales for the first quarter of Fiscal Year 2026 increased by 130% YoY, operating profit turned positive, and net assets grew to approximately 510 billion yen. Continued expansion of new products and businesses strengthens the growth foundation.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"7774","jir_company_name":"Japan Tissue Engineering Co., Ltd.","jir_importance":"\u2605\u2605\u2605\u2605\u2605","jir_publication_date":"2026-07-30","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/07\/7774-20260730-02.pdf","jir_short_summary":"Sales for the first quarter of Fiscal Year 2026 increased by 130% YoY, operating profit turned positive, and net assets grew to approximately 510 billion yen. Continued expansion of new products and businesses strengthens the growth foundation.","jir_summary":"### Performance Overview\nIn the first quarter of FY2026, the Company achieved sales of 766 million yen (+130% YoY), operating profit of 59 million yen (turned positive compared to the same period last year), and net assets of 5,142 million yen (+52 million yen compared to the previous period). We are strengthening our revenue base and accelerating growth through new product launches and business expansion.\n\n### Future Outlook and Investor Impact\nWe will continue promoting new product development and business expansion, aiming to enhance profitability and financial stability. For investors, the sustained growth foundation and profitability improvement promise long-term value creation.","jir_financial_highlights":"Sales: 766 million yen (Up 340 million yen YoY)\nOperating Income: 59 million yen (Up 94 million yen from the same period last year)\nNet Assets: 5,142 million yen (Up 52 million yen from the previous fiscal year)","jir_category":"","jir_hashtags":"#JapanTissueEngineering, #FinancialResults, #JapanStocks","jir_key_figures":"Sales: 766 million yen (up 340 million yen YoY)\nOperating Income: 59 million yen (up 94 million yen YoY)\nNet Assets: 5,142 million yen (up 52 million yen from the previous period)","jir_meta_title":"\u3010Japan Tissue Engineering\u3011Q1 FY2026 Financial Results\uff5cSales 766 million yen (+130%)","jir_meta_description":"Overview of Japan Tissue Engineering\u2019s Q1 FY2026 financial results. Achieved sales of 766 million yen, operating profit turning positive, and increased net assets, with strong growth outlook. Details here.","jir_og_title":"\u3010Japan Tissue Engineering\u3011FY2026 Results\uff5cSales 766 million yen","jir_og_description":"Latest financial results for Japan Tissue Engineering. Achieved revenue growth and profitability, fostering high expectations for future growth.","jir_og_image_url":"\/assets\/og\/company-financial_summary.jpg","jir_chart_data_collection":"[{\"jir_chart_id\": \"revenue_trend\", \"jir_chart_type\": \"line\", \"jir_chart_title\": \"Sales Trend\", \"jir_chart_json_data\": \"{\\\"labels\\\": [\\\"2026\/4\\\", \\\"2026\/5\\\", \\\"2026\/6\\\"], \\\"datasets\\\": [{\\\"label\\\": \\\"Sales\\\", \\\"data\\\": [766, 766, 766], \\\"borderColor\\\": \\\"#36A2EB\\\", \\\"fill\\\": false}]} \"}, {\"jir_chart_id\": \"profit_trend\", \"jir_chart_type\": \"line\", \"jir_chart_title\": \"Operating Income Trend\", \"jir_chart_json_data\": \"{\\\"labels\\\": [\\\"2026\/4\\\", \\\"2026\/5\\\", \\\"2026\/6\\\"], \\\"datasets\\\": [{\\\"label\\\": \\\"Operating Income\\\", \\\"data\\\": [59, 59, 59], \\\"borderColor\\\": \\\"#FF6384\\\", \\\"fill\\\": false}]} \"}]","ir_related_company":57771,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"financial_summary","footnotes":""},"sector":[],"importance":[],"class_list":["post-89835","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n